HistologiX Ltd is based in the East Midlands, a region with one of the highest proportions of non-Living Wage jobs in the country (24%), with over 429,000 jobs paying less than the real Living Wage. Despite this, HistologiX Ltd has committed to pay the real Living Wage and deliver a fair day’s pay for a hard day’s work.
The real Living Wage is the only rate calculated according to the costs of living. It provides a voluntary benchmark for employers that wish to ensure their staff earn a wage they can live on, not just the government minimum. Since 2011 the Living Wage movement has delivered a pay rise to over 160,000 people and put over £800m extra into the pockets of low paid workers.
Andrew Lawrence, Director said "As a responsible employer it was important for us to ensure that every single person in our company earns a living wage, and we are very proud to be Living Wage accredited. We have been paying our employees at least a living wage for some time and obtaining the Living Wage accreditation was a natural progression of this. We believe that by continuing to pay the Living Wage, it will help us to retain, attract and recruit good employees and so sustain our future growth and success"
Tess Lanning, Director, Living Wage Foundation said: “We’re delighted that HistologiX Ltdhas joined the movement of over 4,700 responsible employers across the UK who voluntarily commit to go further than the government minimum to make sure all their staff earn enough to live on."
“They join thousands of small businesses, as well as household names such as IKEA, Heathrow Airport, Barclays, Chelsea and Everton Football Clubs and many more. These businesses recognise that paying the real Living Wage is the mark of a responsible employer and they, like Histologix Ltd, believe that a hard day’s work deserves a fair day’s pay."
About the Living Wage
The real Living Wage is the only rate calculated according to what people need to make ends meet. It provides a voluntary benchmark for employers that choose to take a stand by ensuring their staff earn a wage that meets the costs and pressures they face in their everyday lives.
The UK Living Wage is currently £9.00 per hour. There is a separate London Living Wage rate of £10.55 per hour to reflect the higher costs of transport, childcare and housing in the capital. These figures are calculated annually by the Resolution Foundation and overseen by the Living Wage Commission, based on the best available evidence on living standards in London and the UK.
The Living Wage Foundation is the organisation at the heart of the movement of businesses, organisations and individuals who campaign for the simple idea that a hard day’s work deserves a fair day’s pay. The Living Wage Foundation receives guidance and advice from the Living Wage Advisory Council. The Foundation is supported by our principal partners: Aviva; IKEA; Joseph Rowntree Foundation; KPMG; Linklaters; Nationwide; Nestle; Resolution Foundation; Oxfam; Trust for London; People’s Health Trust; and Queen Mary University of London.
What about the Government’s national living wage?
In July 2015 the Chancellor of the Exchequer announced that the UK Government would introduce a compulsory ‘national living wage’. This new government rate is a new minimum wage rate for staff over 25 years old. It was introduced in April 2016 and the rate is £7.83 per hour as of April 2018. The rate is different to the Living Wage rates calculated by the Living Wage Foundation. The government rate is based on median earnings while the Living Wage Foundation rates are calculated according to the cost of living in London and the UK.
HistologiX Ltd – is a Leading Independent UK Specialist histopathology company, which is GLP accredited and GCP compliant, providing precision quantitative IHC/ISH, histology services and solutions. HistologiX can assist with immunohistochemistry and in-situ hybridisation, tissue sourcing, Medical/Veterinary Pathologist review, target development and distribution, efficacy studies, xenograft studies, tissue cross-reactivity of therapeutic antibodies and patient recruitment/stratification.